Illumina Ventures

What is Illumina Ventures?

Illumina Ventures is an independently managed venture capital firm founded in 2016, with its headquarters situated in Foster City, California, United States. The firm specializes in early-stage investments, focusing on companies that are pioneering new applications in genomics and enabling precision medicine. Illumina Ventures is committed to investing globally in innovative companies that lead the way in genomics and precision health.

The fund's areas of interest include life science tools, clinical diagnostics, therapeutics, digital health, and other sectors influenced by genomics. With assets under management amounting to $230 million, the fund is dedicated to supporting transformative companies that improve human health and the delivery of healthcare.

Investment sizes range from a minimum of $500,000 to a maximum of $10 million, with a sweet spot of around $5 million for each commitment. Illumina Ventures takes pride in its diverse investors and includes a specialization in backing female investors.

It provides capital through various stages including seed, early, and Series A rounds. Additionally, they are passionate about building the genomics ecosystem and translating investments into innovation, which in turn accelerates the impact on various aspects of human health. By investing in key technologies and platforms, Illumina Ventures enables advancements in fields such as biomolecule structural analysis, single-cell RNA sequencing efficiency, cell-based therapeutics, and innovative gene editing approaches.

What they say:

We invest globally in pioneering companies in genomics and precision health, in markets such as life science tools, clinical diagnostics, therapeutics, digital health, and other areas impacted by genomics.